Cita APA

Ribera, J. M., Gimeno Vázquez, E., & Sancho, J. M. (2024). Feasibility and outcomes after dose reduction of immunochemotherapy in young adults with Burkitt lymphoma and leukemia: Results of the BURKIMAB14 trial.

Citación estilo Chicago

Ribera, Josep Maria, Eva Gimeno Vázquez, y Juan Manuel Sancho. Feasibility and Outcomes After Dose Reduction of Immunochemotherapy in Young Adults With Burkitt Lymphoma and Leukemia: Results of the BURKIMAB14 Trial. 2024.

Cita MLA

Ribera, Josep Maria, Eva Gimeno Vázquez, y Juan Manuel Sancho. Feasibility and Outcomes After Dose Reduction of Immunochemotherapy in Young Adults With Burkitt Lymphoma and Leukemia: Results of the BURKIMAB14 Trial. 2024.